Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis.

摘要: Objective To examine the clinical outcomes and costs associated with Staphylococcus aureus bacteremia among hemodialysis-dependent patients. Design Prospectively identified cohort study. Setting A tertiary-care university medical center in North Carolina. Patients Two hundred ten adults end-stage renal disease hospitalized S. bacteremia. Results The majority of patients (117; 55.7%) underwent dialysis via tunneled catheters, 29.5% (62) synthetic arteriovenous fistulas. Vascular access was suspected source 185 (88.1%). Complications occurred 31.0% (65), overall 12-week mortality rate 19.0% (40). mean cost treating bacteremia, including readmissions outpatient costs, $24,034 per episode. initial hospitalization significantly greater for complicated versus uncomplicated ($32,462 vs $17,011; P = .002). Conclusion Interventions to decrease are needed this high-risk, population.